<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: According to the revised Bethesda Guidelines, <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) occurring under age 50 years should be screened to exclude <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, in current practice in East Anglia, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> screening is initiated only after genetics referral, reserved for those with a strong pedigree </plain></SENT>
<SENT sid="2" pm="."><plain>This study aimed to determine how many patients with young-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> undergo <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> screening in hospitals in East Anglia </plain></SENT>
<SENT sid="3" pm="."><plain>METHOD: A retrospective case notes review over 5 years in four hospitals was undertaken to determine what proportion of those with young-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> underwent referral for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> screening and to assess local practices in terms of patient counselling and management </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: One hundred and twenty-two patients were included </plain></SENT>
<SENT sid="5" pm="."><plain>There was an average yearly caseload of 6-9 patients per hospital </plain></SENT>
<SENT sid="6" pm="."><plain>Documented family history was rare, as was counselling concerning metachronous and extra-<z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colonic tumour</z:e> risk and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk in relatives </plain></SENT>
<SENT sid="7" pm="."><plain>The rate of referral for genetic testing varied from 44% to 65% </plain></SENT>
<SENT sid="8" pm="."><plain>Postoperative colonoscopic surveillance was inconsistent </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Many patients with young-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> are managed as <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, without <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> having been excluded </plain></SENT>
<SENT sid="10" pm="."><plain>This may have implications for survival of patients and any affected relatives </plain></SENT>
<SENT sid="11" pm="."><plain>A streamlined management algorithm for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> screening and genetics referral is recommended </plain></SENT>
</text></document>